All these studies discuss IL-17 in the view that IL-17 contributes to anti-cancer inflammation, but it should be further investigated whether Th17-mediated proinflammatory signaling network actually exhibits anti-cancer property in both localized and advanced ovarian cancers of all histologic types. This evidence concerns the gene IL17A and ovarian cancer.